This product is intended strictly for laboratory research and analytical purposes only.
These products are not intended for human or animal consumption, nor for use in clinical or therapeutic applications. While some specific peptide-based medications have received FDA approval for medical use, the research-grade products provided here have not been evaluated, tested, or approved by the FDA or any other regulatory authority for safety, efficacy, or suitability for human or animal use.
Product name: MOTS-c
Purity: 99%
Physical form: Lyophilised solid
Molecular type: Mitochondrial derived peptide (MDP)
Chain length: 16 Amino acids
Molecular formula: C1₀₁ H₁₅₂ N₂₈ O₂₂ S₂
Molecular weight: Approximately 2174.62 gmol
Primary identifier: CAS # 1627580-64-6
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a mitochondrial-derived peptide encoded by the mitochondrial DNA that functions as a systemic signaling molecule to regulate cellular metabolism and mitochondrial homeostasis. In experimental research, this compound is primarily investigated for its role as an “exercise-mimetic” due to its ability to modulate the AMPK signaling pathway, which enhances fatty acid oxidation and improves insulin sensitivity. Studies further explore its capacity to mitigate age-related metabolic decline, including its potential to prevent diet-induced obesity, improve glucose uptake, and support skeletal muscle function during metabolic stress. By facilitating the adaptive response to physiological stressors, MOTS-c is also researched for its potential to reduce chronic inflammation and oxidative stress across various tissues. As a potent research-grade compound, its application remains strictly confined to controlled scientific environments.
This product is intended strictly for laboratory research and analytical purposes only.
CoA available
